BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 35993712)

  • 1. Hepatitis B Virus-Encoded HBsAg Contributes to Hepatocarcinogenesis by Inducing the Oncogenic Long Noncoding RNA LINC00665 through the NF-κB Pathway.
    Ahluwalia S; Ahmad B; Salim U; Ghosh D; Kamuju V; Ghosh A; Dabeer K; Menon MB; Vivekanandan P
    Microbiol Spectr; 2022 Oct; 10(5):e0273121. PubMed ID: 35993712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammation-Induced Long Intergenic Noncoding RNA (LINC00665) Increases Malignancy Through Activating the Double-Stranded RNA-Activated Protein Kinase/Nuclear Factor Kappa B Pathway in Hepatocellular Carcinoma.
    Ding J; Zhao J; Huan L; Liu Y; Qiao Y; Wang Z; Chen Z; Huang S; Zhao Y; He X
    Hepatology; 2020 Nov; 72(5):1666-1681. PubMed ID: 32083756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CRISPR/Cas9-mediated knockout of HBsAg inhibits proliferation and tumorigenicity of HBV-positive hepatocellular carcinoma cells.
    Song J; Zhang X; Ge Q; Yuan C; Chu L; Liang HF; Liao Z; Liu Q; Zhang Z; Zhang B
    J Cell Biochem; 2018 Nov; 119(10):8419-8431. PubMed ID: 29904948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Canonical NF-κB signaling in hepatocytes acts as a tumor-suppressor in hepatitis B virus surface antigen-driven hepatocellular carcinoma by controlling the unfolded protein response.
    Sunami Y; Ringelhan M; Kokai E; Lu M; O'Connor T; Lorentzen A; Weber A; Rodewald AK; Müllhaupt B; Terracciano L; Gul S; Wissel S; Leithäuser F; Krappmann D; Riedl P; Hartmann D; Schirmbeck R; Strnad P; Hüser N; Kleeff J; Friess H; Schmid RM; Geisler F; Wirth T; Heikenwalder M
    Hepatology; 2016 May; 63(5):1592-607. PubMed ID: 26892811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long non-coding RNA F11-AS1 inhibits HBV-related hepatocellular carcinoma progression by regulating NR1I3 via binding to microRNA-211-5p.
    Deng Y; Wei Z; Huang M; Xu G; Wei W; Peng B; Nong S; Qin H
    J Cell Mol Med; 2020 Jan; 24(2):1848-1865. PubMed ID: 31880390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long Noncoding RNA TFAP2A-AS1 Suppressed Hepatitis B Virus Replication by Modulating miR-933/HDAC11.
    Cheng Y; Shi W; Cui X; Sun L; Nan Y; Yao H; Fan J; Zhu L; Yu L
    Dis Markers; 2022; 2022():7733390. PubMed ID: 35478990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA PCNAP1 modulates hepatitis B virus replication and enhances tumor growth of liver cancer.
    Feng J; Yang G; Liu Y; Gao Y; Zhao M; Bu Y; Yuan H; Yuan Y; Yun H; Sun M; Gao H; Zhang S; Liu Z; Yin M; Song X; Miao Z; Lin Z; Zhang X
    Theranostics; 2019; 9(18):5227-5245. PubMed ID: 31410212
    [No Abstract]   [Full Text] [Related]  

  • 8. Hepatitis B Virus Small Envelope Protein Promotes Hepatocellular Carcinoma Angiogenesis via Endoplasmic Reticulum Stress Signaling To Upregulate the Expression of Vascular Endothelial Growth Factor A.
    Wu SX; Ye SS; Hong YX; Chen Y; Wang B; Lin XJ; Lin X
    J Virol; 2022 Feb; 96(4):e0197521. PubMed ID: 34910612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrahepatic hepatitis B virus large surface antigen induces hepatocyte hyperploidy via failure of cytokinesis.
    Li TN; Wu YJ; Tsai HW; Sun CP; Wu YH; Wu HL; Pei YN; Lu KY; Yen TT; Chang CW; Chan HL; Tao MH; Liou JY; Chang MD; Su IJ; Wang LH
    J Pathol; 2018 Aug; 245(4):502-513. PubMed ID: 29862509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis B Surface Antigen Promotes the Invasion of Hepatitis B Virus-Related Hepatocellular Carcinoma Cells by Upregulation of Toll-Like Receptor 2.
    Cheng S; Zhang B; Du JY; Jin YH; Lang HY; Zeng LH
    Viral Immunol; 2017 Apr; 30(3):232-239. PubMed ID: 28061318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ATP1B3 cooperates with BST-2 to promote hepatitis B virus restriction.
    Zheng B; Zhang J; Zheng T; Wang H; Li Z; Huan C; Ning S; Wang Y; Zhang W
    J Med Virol; 2020 Feb; 92(2):201-209. PubMed ID: 31556466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HBx-induced MiR-1269b in NF-κB dependent manner upregulates cell division cycle 40 homolog (CDC40) to promote proliferation and migration in hepatoma cells.
    Kong XX; Lv YR; Shao LP; Nong XY; Zhang GL; Zhang Y; Fan HX; Liu M; Li X; Tang H
    J Transl Med; 2016 Jun; 14(1):189. PubMed ID: 27349221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Linc00152 promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma.
    Deng X; Zhao XF; Liang XQ; Chen R; Pan YF; Liang J
    Biomed Pharmacother; 2017 Jun; 90():100-108. PubMed ID: 28343069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HBx-related long non-coding RNA DBH-AS1 promotes cell proliferation and survival by activating MAPK signaling in hepatocellular carcinoma.
    Huang JL; Ren TY; Cao SW; Zheng SH; Hu XM; Hu YW; Lin L; Chen J; Zheng L; Wang Q
    Oncotarget; 2015 Oct; 6(32):33791-804. PubMed ID: 26393879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B virus X protein-induced SH2 domain-containing 5 (SH2D5) expression promotes hepatoma cell growth via an SH2D5-transketolase interaction.
    Zheng Y; Ming P; Zhu C; Si Y; Xu S; Chen A; Wang J; Zhang B
    J Biol Chem; 2019 Mar; 294(13):4815-4827. PubMed ID: 30659097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel HBsAg mutations correlate with hepatocellular carcinoma, hamper HBsAg secretion and promote cell proliferation in vitro.
    Salpini R; Surdo M; Warner N; Cortese MF; Colledge D; Soppe S; Bellocchi MC; Armenia D; Carioti L; Continenza F; Di Carlo D; Saccomandi P; Mirabelli C; Pollicita M; Longo R; Romano S; Cappiello G; Spanò A; Trimoulet P; Fleury H; Vecchiet J; Iapadre N; Barlattani A; Bertoli A; Mari T; Pasquazzi C; Missale G; Sarrecchia C; Orecchini E; Michienzi A; Andreoni M; Francioso S; Angelico M; Verheyen J; Ceccherini-Silberstein F; Locarnini S; Perno CF; Svicher V
    Oncotarget; 2017 Feb; 8(9):15704-15715. PubMed ID: 28152517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined identification of three lncRNAs in serum as effective diagnostic and prognostic biomarkers for hepatitis B virus-related hepatocellular carcinoma.
    Fu P; Gong B; Li H; Luo Q; Huang Z; Shan R; Li J; Yan S
    Int J Cancer; 2022 Nov; 151(10):1824-1834. PubMed ID: 35802466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA NKILA inhibits HBV replication by repressing NF-κB signalling activation.
    Zhang X; Li Y; Huan C; Hou Y; Liu R; Shi H; Zhang P; Zheng B; Wang Y; Wang H; Zhang W
    Virol Sin; 2024 Feb; 39(1):44-55. PubMed ID: 37832719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B virus X protein induces EpCAM expression via active DNA demethylation directed by RelA in complex with EZH2 and TET2.
    Fan H; Zhang H; Pascuzzi PE; Andrisani O
    Oncogene; 2016 Feb; 35(6):715-26. PubMed ID: 25893293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HBsAg/β2GPI activates the NF‑κB pathway via the TLR4/MyD88/IκBα axis in hepatocellular carcinoma.
    Jing X; Tian Z; Gao P; Xiao H; Qi X; Yu Y; Ding X; Yang L; Zong L
    Oncol Rep; 2018 Aug; 40(2):1035-1045. PubMed ID: 29916535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.